XML 49 R88.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Parent Company Only, Statements of Cash Flows (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities [Abstract]      
Net income $ 57,840 $ 61,445 $ 43,145
Adjustments to reconcile net income to net cash provided by operating activities [Abstract]      
Stock based compensation expense 5 173 150
Total adjustments 5,958 6,195 18,545
Net cash provided by operating activities 63,798 67,640 61,690
Cash flows from financing activities [Abstract]      
Proceeds from exercise of stock options 185 1,259 5,237
Dividends paid (26,385) (25,569) (25,197)
Purchases of treasury stock (35) (718) (4,608)
Proceeds from sales of treasury stock 1,791 2,391 2,480
Net cash provided by (used in) financing activities 138,098 (2,851) (11,340)
Net decrease in cash and cash equivalents (46,863) (109,031) (94,534)
Cash and cash equivalents at beginning of period 503,709 612,740 707,274
Cash and cash equivalents at end of period 456,846 503,709 612,740
TrustCo Bank Corp NY [Member]      
Cash flows from operating activities [Abstract]      
Net income 57,840 61,445 43,145
Adjustments to reconcile net income to net cash provided by operating activities [Abstract]      
Equity in undistributed earnings of subsidiaries (32,207) (38,317) (20,185)
Stock based compensation expense 5 173 150
Net change in other assets and accrued expenses 246 214 853
Total adjustments (31,956) (37,930) (19,182)
Net cash provided by operating activities 25,884 23,515 23,963
Cash flows from financing activities [Abstract]      
Proceeds from exercise of stock options 185 1,259 5,236
Dividends paid (26,372) (25,555) (25,184)
Purchases of treasury stock (35) (718) (4,608)
Proceeds from sales of treasury stock 1,791 2,391 2,480
Net cash provided by (used in) financing activities (24,431) (22,623) (22,076)
Net decrease in cash and cash equivalents 1,453 892 1,887
Cash and cash equivalents at beginning of period 22,665 21,773 19,886
Cash and cash equivalents at end of period $ 24,118 $ 22,665 $ 21,773